We welcome Dr. Richard Auchus as he discusses congenital adrenal hyperplasia (CAH), its current treatments, and introduces a groundbreaking drug, Crenessity (crinecerfont), that could revolutionize management of the condition.
We welcome Dr. Richard Auchus as he discusses congenital adrenal hyperplasia (CAH), its current treatments, and introduces a groundbreaking drug, Crenessity (crinecerfont), that could revolutionize management of the condition.
Interviews, expert presentations, and the latest treatment data — all from this year’s largest endocrinology meeting. From J D Faccinetti co-founder – The annual international endocrine conference ENDO 2026, which just ended in Chicago, yielded a
In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.